ArticleFrontiers in oncology2021

Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Characteristics.

Hui Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.